Skip to main content
Signal8

Jung Mira

SEC insider (Form 3/4/5 filer). CIK 0001945307. Chief Scientific Officer at Shuttle Pharmaceuticals Holdings, Inc. (SHPH). 1 reported Form 4/5 transaction since Sep 2024; latest on May 1, 2024. Located in ROCKVILLE, MD.

Companies Jung Mira has filed insider reports for

  • Shuttle Pharmaceuticals Holdings, Inc. (SHPH): Officer, Chief Scientific Officer
Jung Mira profile photo

Jung Mira

CIK: 0001945307

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Shuttle Pharmaceuticals Holdings, Inc. logo
SHPH

Shuttle Pharmaceuticals Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Shuttle Pharmaceuticals Holdings, Inc. logo
    SHPH

    Shuttle Pharmaceuticals Holdings, Inc.

    May 1, 2024
    Award
    Direct
    598 shares at avg. $11.28$7K

1-1 of 1